Albiso, Mercedes M.

HRN: 00-57-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/25/2026
05/02/2026
IV
500mg
Q12
Infectious Diarrhea
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines